Home › Funds › GREAT POINT PARTNERS LLC › CGEM

GREAT POINT PARTNERS LLC position in CGEM

CULLINAN THERAPEUTICS INC · Health Care

GREAT POINT PARTNERS LLC reported holding 300,000 shares of CGEM (CULLINAN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 1.15% of its reported portfolio and ranking #27 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed CGEM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)300.00K sh
Reported value held$5.46M
Portfolio Weight1.15%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's CGEM position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in CGEM in Q4 2025 at 634,032 shares (US$6.6M). Across 3 filings, GREAT POINT PARTNERS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 300,000 shares valued at US$5.5M. Notable position changes include a 53% trim in Q1 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 634.03K $6.56M New
Q1 2026 300.00K $4.26M Reduce
Q2 2026 300.00K $5.46M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGEM and 13F data

CGEM (CULLINAN THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in CGEM — the largest reported positions include MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), BVF INC/IL (US$104.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGEM

All CGEM fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held CGEM?

GREAT POINT PARTNERS LLC has disclosed CGEM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is GREAT POINT PARTNERS LLC's current position in CGEM?

As of Q2 2026, GREAT POINT PARTNERS LLC holds 300.00K shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $5.46M, representing 1.15% of its reported portfolio and ranking #27.

Has GREAT POINT PARTNERS LLC been buying or selling CGEM?

In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC held unchanged its position in CGEM.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.